Adjuvanted influenza vaccines
JS Tregoning, RF Russell, E Kinnear - Human vaccines & …, 2018 - Taylor & Francis
In spite of current influenza vaccines being immunogenic, evolution of the influenza virus
can reduce efficacy and so influenza remains a major threat to public health. One approach …
can reduce efficacy and so influenza remains a major threat to public health. One approach …
Influenza vaccines: Past, present, and future
YH Kim, KJ Hong, H Kim… - Reviews in medical …, 2022 - Wiley Online Library
Summary Globally, infection by seasonal influenza viruses causes 3–5 million cases of
severe illness and 290,000–650,000 respiratory deaths each year. Various influenza …
severe illness and 290,000–650,000 respiratory deaths each year. Various influenza …
Inactivated and adjuvanted influenza vaccines
G Del Giudice, R Rappuoli - Influenza Pathogenesis and Control-Volume II, 2014 - Springer
Inactivated influenza vaccines are produced every year to fight against the seasonal
epidemics of influenza. Despite the nonoptimal coverage, even in subjects at risk like the …
epidemics of influenza. Despite the nonoptimal coverage, even in subjects at risk like the …
Is a universal influenza virus vaccine possible?
R Nachbagauer, P Palese - Annual review of medicine, 2020 - annualreviews.org
Influenza viruses remain a severe burden to human health because of their contribution to
overall morbidity and mortality. Current seasonal influenza virus vaccines do not provide …
overall morbidity and mortality. Current seasonal influenza virus vaccines do not provide …
New vaccines against influenza virus
Vaccination is one of the most effective and cost-benefit interventions that prevent the
mortality and reduce morbidity from infectious pathogens. However, the licensed influenza …
mortality and reduce morbidity from infectious pathogens. However, the licensed influenza …
Universal influenza virus vaccines: need for clinical trials
F Krammer, P Palese - Nature immunology, 2014 - nature.com
Universal influenza virus vaccines: need for clinical trials | Nature Immunology Skip to main
content Thank you for visiting nature.com. You are using a browser version with limited support …
content Thank you for visiting nature.com. You are using a browser version with limited support …
Influenza vaccination strategies: comparing inactivated and live attenuated influenza vaccines
S Sridhar, KA Brokstad, RJ Cox - Vaccines, 2015 - mdpi.com
Influenza is a major respiratory pathogen causing annual outbreaks and occasional
pandemics. Influenza vaccination is the major method of prophylaxis. Currently annual …
pandemics. Influenza vaccination is the major method of prophylaxis. Currently annual …
Influenza vaccines for the future
LC Lambert, AS Fauci - New England Journal of Medicine, 2010 - Mass Medical Soc
Influenza Vaccines for the Future | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
Influenza vaccines: challenges and solutions
K Houser, K Subbarao - Cell host & microbe, 2015 - cell.com
Vaccination is the best method for the prevention and control of influenza. Vaccination can
reduce illness and lessen severity of infection. This review focuses on how currently …
reduce illness and lessen severity of infection. This review focuses on how currently …
Emulsion-based adjuvants for influenza vaccines
FR Vogel, C Caillet, IC Kusters… - Expert review of …, 2009 - Taylor & Francis
The ongoing epizootic of highly pathogenic avian H5N1 influenza and its direct
transmissibility and high pathogenicity in humans has led to renewed interest in the …
transmissibility and high pathogenicity in humans has led to renewed interest in the …